Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

EP 201: The gene therapy playbook: Successes, setbacks, and the path forward with Richard Wilson of Astellas

47:28
 
Share
 

Manage episode 501542369 series 2631947
Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This week on The Genetics Podcast, Patrick is joined by Richard Wilson, Senior Vice President, Primary Focus Lead of Genetic Regulation at Astellas. They discuss where the gene therapy field stands today, diving into successes, persistent barriers, regulatory considerations, manufacturing strategies, and other reflections on important approaches to precision medicine drug development.

Show Notes:

0:00 Intro to The Genetics Podcast

00:59 Welcome to Richard

01:33 Current wins and challenges in gene therapy

07:13 The need for more open non-competitive data sharing and a clearer pathway towards reimbursement and incentivization

11:15 Building post-approval systems into the genomic medicine lifecycle

14:47 Rethinking evidence standards in rare disease trials, and the global push for regulatory and reimbursement alignment

20:28 Genetic medicine breakthroughs in central nervous system diseases

22:25 The challenges of starting clinical development with an end in mind

24:34 The need for careful analysis around endpoints, vector design, and delivery approaches

29:33 Navigating regulatory hurdles when making mid-program changes to vectors or payloads

31:16 Strategies for enhancing scalability and quality of gene therapy manufacturing

36:05 Exploring other delivery methods beyond AAV

39:32 Getting ready for the Timmerman Traverse and raising nearly $1M for Life Science Cares

43:48 A call to refocus on patients, partnership, and purpose in uncertain times

45:55 Closing remarks

Find out more

Please consider rating and reviewing us on your chosen podcast listening platform!

https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link

  continue reading

205 episodes

Artwork
iconShare
 
Manage episode 501542369 series 2631947
Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This week on The Genetics Podcast, Patrick is joined by Richard Wilson, Senior Vice President, Primary Focus Lead of Genetic Regulation at Astellas. They discuss where the gene therapy field stands today, diving into successes, persistent barriers, regulatory considerations, manufacturing strategies, and other reflections on important approaches to precision medicine drug development.

Show Notes:

0:00 Intro to The Genetics Podcast

00:59 Welcome to Richard

01:33 Current wins and challenges in gene therapy

07:13 The need for more open non-competitive data sharing and a clearer pathway towards reimbursement and incentivization

11:15 Building post-approval systems into the genomic medicine lifecycle

14:47 Rethinking evidence standards in rare disease trials, and the global push for regulatory and reimbursement alignment

20:28 Genetic medicine breakthroughs in central nervous system diseases

22:25 The challenges of starting clinical development with an end in mind

24:34 The need for careful analysis around endpoints, vector design, and delivery approaches

29:33 Navigating regulatory hurdles when making mid-program changes to vectors or payloads

31:16 Strategies for enhancing scalability and quality of gene therapy manufacturing

36:05 Exploring other delivery methods beyond AAV

39:32 Getting ready for the Timmerman Traverse and raising nearly $1M for Life Science Cares

43:48 A call to refocus on patients, partnership, and purpose in uncertain times

45:55 Closing remarks

Find out more

Please consider rating and reviewing us on your chosen podcast listening platform!

https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link

  continue reading

205 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play